Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism FFAR2 modulators(Free fatty acid receptor 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Lactocore, Inc.Startup |
Active Organization Lactocore, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic Diseases | Preclinical | US | Lactocore, Inc.Startup | - |
Diabetes Mellitus, Type 2 | Discovery | US | Lactocore, Inc.Startup | 01 Dec 2024 |
Diabetic Nephropathies | Discovery | US | Lactocore, Inc.Startup | 01 Dec 2024 |
Well Aging | Discovery | US | Lactocore, Inc.Startup | 01 Dec 2024 |